Drug Type Chemical drugs |
Synonyms KTA-574 |
Target |
Action agonists |
Mechanism THR-β agonists(Thyroid hormone receptor beta agonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Dyslipidemias | Preclinical | Japan | 01 Feb 2013 |